Bortezomib and daratumumab in refractory autoimmune hemolytic anemia

被引：4
|
作者：
McGlothlin, John [1 ,2 ]
Abeykoon, Jithma [1 ]
Al-Hattab, Eyad [1 ]
Ashrani, Aneel A. [1 ]
Elliott, Michelle [1 ]
Hook, C. Christopher [1 ]
Pardanani, Animesh [1 ]
Pruthi, Rajiv [1 ]
Sridharan, Meera [1 ]
Wolanskyj, Alexandra [1 ]
Rouse, Rachelle [1 ]
Go, Ronald [1 ]
机构：
[1] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Internal Med, Rochester, MN 55905 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 10期
关键词：
D O I：
10.1002/ajh.27025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E263 / E265
页数：3
相关论文
共 50 条
  • [1] Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia
    McGlothlin, John
    Abeykoon, Jithma P.
    Al-Hattab, Eyad
    Ashrani, Aneel A.
    Elliott, Michelle A.
    Go, Ronald
    Hook, C. Christopher
    Pardanani, Animesh
    Pruthi, Rajiv K.
    Sridharan, Meera
    Wolanskyj, Alexandra P.
    BLOOD, 2022, 140 : 5328 - 5330
  • [2] Daratumumab for refractory warm autoimmune hemolytic anemia
    Jain, Ankur
    Gupta, D. K.
    ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1351 - 1353
  • [3] Daratumumab for refractory warm autoimmune hemolytic anemia
    Ankur Jain
    D. K. Gupta
    Annals of Hematology, 2021, 100 : 1351 - 1353
  • [4] Daratumumab for Posttransplant Autoimmune Hemolytic Anemia
    Abduallah, Yaqeen
    Kennah, Michael
    Prince, Connor
    Masurekar, Ashish
    Kekre, Natasha
    Nampoothiri, Ram Vasudevan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [5] Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease
    Jalink, Marit
    Jacobs, Chaja F.
    Khwaja, Jahanzaib
    Evers, Dorothea
    Bruggeman, Coty
    Fattizzo, Bruno
    Michel, Marc
    Crickx, Etienne
    Hill, Quentin A.
    Jaeger, Ulrich
    Kater, Arnon P.
    Makelburg, Anja B. U.
    Breedijk, Anouk
    te Boekhorst, Peter A. W.
    Hoeks, Marlijn P. A.
    de Haas, Masja
    D'Sa, Shirley
    Vos, Josephine M. I.
    BLOOD ADVANCES, 2024, 8 (11) : 2622 - 2634
  • [6] Bortezomib in autoimmune hemolytic anemia and beyond
    Pasquale, Raffaella
    Giannotta, Juri Alessandro
    Barcellini, Wilma
    Fattizzo, Bruno
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [7] Bortezomib for the Management of Relapsed or Refractory Warm Autoimmune Hemolytic Anemia: A Scoping Review
    Johnson, Eric
    Lesh, Nicholas
    Hildebrand, Gregory
    Shah, Harsh
    Osman, Afaf
    Abou-Ismail, Mouhamed Yazan
    BLOOD, 2021, 138
  • [8] The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune-Antibody-Mediated Hemolytic Anemia
    Johnson, John Philip
    Ness, Dylan B.
    Lewis, Lionel D.
    Condict, Brittany E.
    Lowrey, Christopher H.
    Sullivan, Matthew R.
    BLOOD, 2024, 144 : 3830 - 3831
  • [9] Refractory Autoimmune Hemolytic Anemia Successfully Treated With Daratumumab in a Patient with MHC Class II Deficiency
    Ngo, Suzanne
    Nakano, Taizo
    Dutmer, Cullen
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S19 - S20
  • [10] Bortezomib for autoimmune hemolytic anemia after intestinal transplantation
    Knops, Noel
    Emonds, Marie-Paule
    Herman, Jean
    Levtchenko, Elena
    Mekahli, Djalila
    Pirenne, Jacques
    Van Geet, Chris
    Dierickx, Daan
    PEDIATRIC TRANSPLANTATION, 2020, 24 (04)
12345